After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, ...
In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.
GlobalData on MSN
Philips powers CT-guided PCI shift with new integration
"Philips powers CT-guided PCI shift with new integration" was originally created and published by Medical Device Network, a ...
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, ...
News-Medical.Net on MSN
Sirolimus-eluting balloon emerges as a safe and effective option for coronary in-stent restenosis
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback